US Drug Recall Register
Class II · Moderate risk Terminated Initiated Mar 24, 2017 (9 years ago)

Estrone Micronized

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

cGMP Deviations; lack of quality assurance.

What was recalled

Estrone Micronized, USP, Bulk, Rx only, For Prescription Compounding, Manufactured by Qinhuangdao Zizhu Pharmaceutical Co., Ltd., Qinhuangdao 066004, China (NDC 44132-003-04) (NDC 44132-003-02)(NDC 44132-003-06)

Recalling firm
Qinhuangdao Zizhu Pharmaceutical, Co.
NDC code
44132-003-04
Origin
N/A, China
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0657-2017

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Estrone recalls

See all
Class II · Moderate risk Terminated

Estrone 5mg/mL Oil Injection

Reason Lack of sterility assurance.

Anderson Compounding Pharmacy, Inc. DBA Anderson Compounding Pharmacy D-1195-2019
Class II · Moderate risk Terminated

Estrone USP for prescription compounding

Reason CGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system.

American Pharmaceutical Ingredients LLC NDC 58597-8049-3 D-0491-2018
Class II · Moderate risk Terminated

Estrone USP

Reason cGMP Deviations; lack of quality assurance.

American Pharmaceutical Ingredients LLC D-0919-2017
Class II · Moderate risk Terminated

Estrone

Reason cGMP Deviations: lack of quality assurance at the API manufacturer.

Fagron, Inc NDC 51552-0445-2 D-0792-2017
Class II · Moderate risk Terminated

Estrone

Reason cGMP Deviations; manufacturer initiated recall of API product after deficiencies noted during a recent FDA inspection

Medisca, Inc. NDC 38779-0891-05 D-0664-2017